JP2024503703A5 - - Google Patents
Info
- Publication number
- JP2024503703A5 JP2024503703A5 JP2023543064A JP2023543064A JP2024503703A5 JP 2024503703 A5 JP2024503703 A5 JP 2024503703A5 JP 2023543064 A JP2023543064 A JP 2023543064A JP 2023543064 A JP2023543064 A JP 2023543064A JP 2024503703 A5 JP2024503703 A5 JP 2024503703A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- armed
- cancer
- seneca valley
- valley virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163138999P | 2021-01-19 | 2021-01-19 | |
| US63/138,999 | 2021-01-19 | ||
| PCT/US2022/013001 WO2022159508A1 (en) | 2021-01-19 | 2022-01-19 | Armed seneca valley virus oncolytic therapy compositions and methods thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503703A JP2024503703A (ja) | 2024-01-26 |
| JP2024503703A5 true JP2024503703A5 (https=) | 2025-01-22 |
Family
ID=82549037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543064A Pending JP2024503703A (ja) | 2021-01-19 | 2022-01-19 | 武装型セネカバレーウイルス腫瘍溶解療法組成物およびその方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240307470A1 (https=) |
| EP (1) | EP4281549A4 (https=) |
| JP (1) | JP2024503703A (https=) |
| KR (1) | KR20230134524A (https=) |
| CN (1) | CN116761883A (https=) |
| AU (1) | AU2022210419A1 (https=) |
| CA (1) | CA3207261A1 (https=) |
| IL (1) | IL304280A (https=) |
| WO (1) | WO2022159508A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240076343A1 (en) | 2022-06-16 | 2024-03-07 | Cephalon Llc | Anti-pd-1 antibody-attenuated il-2 immunoconjugates and uses thereof |
| WO2024177972A2 (en) * | 2023-02-20 | 2024-08-29 | The Wistar Institute Of Anatomy And Biology | Antibody-cytokine chimeras |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7638318B2 (en) * | 2003-09-26 | 2009-12-29 | Norvartis Ag | Seneca Valley virus based compositions and methods for treating disease |
| SG192673A1 (en) * | 2011-02-10 | 2013-09-30 | Roche Glycart Ag | Mutant interleukin-2 polypeptides |
| EA201892619A1 (ru) * | 2011-04-29 | 2019-04-30 | Роше Гликарт Аг | Иммуноконъюгаты, содержащие мутантные полипептиды интерлейкина-2 |
| RU2696312C2 (ru) * | 2014-07-16 | 2019-08-01 | Трансген Са | Онколитический вирус для экспрессии модуляторов иммунологических контрольных точек |
| CN111201035A (zh) * | 2017-06-19 | 2020-05-26 | 梅迪塞纳医疗股份有限公司 | Il-2超激动剂、激动剂及其融合体的用途和方法 |
| MX2021001883A (es) * | 2018-08-16 | 2021-07-15 | Musc Found For Res Dev | Virus recombinantes del mixoma y usos de los mismos. |
| US20220000921A1 (en) * | 2018-11-20 | 2022-01-06 | Innovative Cellular Therapeutics Holdings, Ltd. | Modified Cell Expressing Therapeutic Agent and Uses thereof |
| JP2022516318A (ja) * | 2019-01-04 | 2022-02-25 | オンコラス， インコーポレイテッド | カプセル化ポリヌクレオチド及び使用方法 |
| US20220119478A1 (en) * | 2019-01-15 | 2022-04-21 | Caerus Therapeutics, Corp. | Advanced chimeric antigen receptor vectors for targeting solid tumors |
| CN111154806A (zh) * | 2020-01-08 | 2020-05-15 | 深圳普菲科生命科技有限公司 | 一种嵌合外源超级细胞因子的溶瘤病毒载体系统及其在药物中的应用 |
| CA3207860A1 (en) * | 2021-01-11 | 2022-07-14 | Seneca Therapeutics, Inc. | Seneca valley virus combination therapy to treat a cancer refractory to a checkpoint inhibitor |
-
2022
- 2022-01-19 EP EP22743116.0A patent/EP4281549A4/en active Pending
- 2022-01-19 KR KR1020237027681A patent/KR20230134524A/ko active Pending
- 2022-01-19 AU AU2022210419A patent/AU2022210419A1/en active Pending
- 2022-01-19 US US18/272,986 patent/US20240307470A1/en active Pending
- 2022-01-19 WO PCT/US2022/013001 patent/WO2022159508A1/en not_active Ceased
- 2022-01-19 JP JP2023543064A patent/JP2024503703A/ja active Pending
- 2022-01-19 CN CN202280010849.XA patent/CN116761883A/zh active Pending
- 2022-01-19 CA CA3207261A patent/CA3207261A1/en active Pending
-
2023
- 2023-07-05 IL IL304280A patent/IL304280A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kwon et al. | mRNA vaccines: the most recent clinical applications of synthetic mRNA | |
| KR20210039401A (ko) | 원형 폴리리보뉴클레오티드를 포함하는 조성물 및 이의 용도 | |
| JP2020506189A (ja) | Ｒｎａ癌ワクチン | |
| Yu et al. | Optimized circular RNA vaccines for superior cancer immunotherapy | |
| CN105377867A (zh) | I型干扰素的环状二核苷酸诱导 | |
| US20240182538A1 (en) | Modulation of ifi16 and sting activity | |
| EP4458843A1 (en) | Mrna vaccine | |
| JP2024503703A5 (https=) | ||
| KR20240006603A (ko) | 변형된 리보핵산 및 이의 용도 | |
| CN105859890A (zh) | 嵌合抗原受体及其基因和重组表达载体、工程化cd30靶向性的nkt细胞及其应用 | |
| CN113249380B (zh) | 靶向covid-19新冠病毒的反义寡核苷酸、natac嵌合分子及其应用 | |
| JP2025509106A (ja) | タンパク質発現を増強するための、配列内リボソーム進入部位（ＩＲＥＳ）、プラスミドベクター及び環状ｍＲＮＡ | |
| CN117337329A (zh) | 环状rna | |
| CN116710079A (zh) | 包含经修饰的核苷酸的脂质纳米颗粒 | |
| JP2024509123A (ja) | 合成リボ核酸（ｒｎａ）からのタンパク質発現を向上させる組換え発現構築物 | |
| CN110387353B (zh) | 一种用于治疗肿瘤的柯萨奇b组病毒 | |
| JP2024503000A (ja) | 発現構築物およびその使用 | |
| CN105367661B (zh) | 嵌合抗原受体及其基因和重组表达载体、工程化her1靶向性的nkt细胞及其应用 | |
| JP2022500054A (ja) | 抗腫瘍アレナウイルスおよびアレナウイルス変異体を生産するための方法 | |
| CN105924526A (zh) | 嵌合抗原受体及其基因和重组表达载体、carher1-nkt细胞及其制备方法和应用 | |
| CN117957328A (zh) | 多核苷酸及其用途 | |
| CN105384823A (zh) | 嵌合抗原受体及其基因和重组表达载体、工程化cd33靶向性的nkt细胞及其应用 | |
| CN109419818B (zh) | 一种用于治疗肿瘤的埃可病毒 | |
| JP7642824B2 (ja) | 遺伝子発現および抑制が同時に可能な核酸構造体 | |
| CN105920592B (zh) | Carher1-nkt细胞在制备用于治疗进展期her1阳性肺癌的制剂中的应用 |